1. Boellaard R.,
Delgado-Bolton R.,
Oyen W.J.,
et al.
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 // Eur.
J.
Nucl.
Med.
Mol.
Imaging.
– 2015.
– Vol.
42,
N 2.
– P.
328-354.
2. Cheson B.D.,
Fisher R.I.,
Barrington S.F.,
et al.
Recommendations for initial evaluation,
staging,
and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification // J.
Clin.
Oncol.
– 2014.
– Vol.
32,
N 27.
– P.
3059-68.
3. Barrington S.F.,
Mikhaeel N.G.,
Kostakoglu L.,
et al.
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group // J.
Clin.
Oncol.
– 2014.
– Vol.
32,
N 27.
– P.
3048-3058.
4. Meignan M.,
Itti E.,
Gallamini A.,
Younes A.
FDG PET/CT imaging as a biomarker in lymphoma // Eur.
J.
Nucl.
Med.
Mol.
Imaging.
– 2015.
– Vol.
42,
N 4.
– P.
623-633.
5. Younes A.,
Hilden P.,
Coiffier B.,
et al.
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) // Ann.
Oncol.
– 2017.
– Vol.
28.
– P.
1436–1447.
6. Barrington S.F.,
Qian W.,
Somer E.J.,
et al.
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma // Eur.
J.
Nucl.
Med.
Mol.
Imaging.
– 2010.
– Vol.
37,
N 10.
– P.
1824-1833.